These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8847018)

  • 41. Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide.
    Oberg K; Norheim I; Theodorsson E
    Acta Oncol; 1991; 30(4):503-7. PubMed ID: 1854508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Individual therapeutic procedure in metastatic carcinoid of the small intestine].
    Barthel A; Leonhardt U; Stöckmann F; Ramadori G
    Leber Magen Darm; 1996 May; 26(3):164, 167-9. PubMed ID: 8709831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tumour vanishes.
    Todd JF; Meeran K
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
    [No Abstract]   [Full Text] [Related]  

  • 44. (131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome.
    Pathirana AA; Vinjamuri S; Byrne C; Ghaneh P; Vora J; Poston GJ
    Eur J Surg Oncol; 2001 Jun; 27(4):404-8. PubMed ID: 11417988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of the carcinoid syndrome with somatostatin, salmon calcitonin, or octreotide.
    Antonelli A; Gambuzza C; Bertoni F; Baschieri L
    Clin Ther; 1992; 14(2):178-84. PubMed ID: 1377097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
    Søndenaa K; Sen J; Heinle F; Fjetland L; Gudlaugsson E; Syversen U
    World J Surg; 2004 Sep; 28(9):890-5. PubMed ID: 15593463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.
    Leong WL; Pasieka JL
    J Surg Oncol; 2002 Mar; 79(3):180-7. PubMed ID: 11870669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Management of digestive system carcinoid tumors and carcinoid syndrome].
    Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment.
    Pregun I; Gergics P; Dabasi G; Igaz P; Racz K; Tulassay Z
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):476-7. PubMed ID: 19382304
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
    Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
    Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.
    Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J
    Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue.
    Manfredi S; Pagenault M; de Lajarte-Thirouard AS; Bretagne JF
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):1021-5. PubMed ID: 18049175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A case of rectal carcinoid with multiple liver, lymph nodes and bone metastases that responded to an octreotide therapy].
    Yamashita K; Takase S; Nakamura T; Matsuda Y; Imanishi T; Sumi Y; Suzuki S; Kamigaki T; Ku Y; Kuroda D
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2349-51. PubMed ID: 21224569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of carcinoid syndrome with recombinant interferon alpha-2a.
    Di Bartolomeo M; Bajetta E; Zilembo N; de Braud F; Di Leo A; Verusio C; D'Aprile M; Scanni A; Barduagni M; Barduagni A [corrected to Barduagni M]
    Acta Oncol; 1993; 32(2):235-8. PubMed ID: 7686766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carcinoid tumors of the gastrointestinal tract. A review and the Duke University institutional overview.
    Onaitis M; White R; Tyler D
    Minerva Chir; 2003 Feb; 58(1):1-8. PubMed ID: 12692491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide.
    Filosso PL; Ruffini E; Oliaro A; Papalia E; Donati G; Rena O
    Eur J Cardiothorac Surg; 2002 May; 21(5):913-7. PubMed ID: 12062286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
    Ahren B; Engman K; Lindblom A
    Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastatic carcinoid tumor: changing patterns of care over two decades.
    Townsend A; Price T; Yeend S; Pittman K; Patterson K; Luke C
    J Clin Gastroenterol; 2010 Mar; 44(3):195-9. PubMed ID: 19609217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up of patients with ECL cell-derived tumours.
    Sagatun L; Fossmark R; Jianu CS; Qvigstad G; Nordrum IS; Mjønes P; Waldum HL
    Scand J Gastroenterol; 2016 Nov; 51(11):1398-405. PubMed ID: 27309188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.